|   |   | 
Legal status
Patent in force
| (51) | INT.CL. | A61P 31/00 | (2006.01) | 
| A61K 39/395 | (2006.01) | ||
| A61K 9/19 | (2006.01) | ||
| A61K 9/00 | (2006.01) | ||
| A61K 47/18 | (2017.01) | ||
| A61K 47/26 | (2006.01) | ||
| A61P 31/12 | (2006.01) | ||
| A61P 35/00 | (2006.01) | ||
| C07K 16/28 | (2006.01) | ||
| A61K 39/00 | (2006.01) | 
| (11) | Number of the document | 2691112 | 
| (13) | Kind of document | T | 
| (96) | European patent application number | 12763896.3 | 
| Date of filing the European patent application | 2012-03-29 | |
| (97) | Date of publication of the European application | 2014-02-05 | 
| (45) | Date of publication and mention of the grant of the patent | 2018-05-23 | 
| (46) | Date of publication of the claims translation | 2018-07-25 | 
| (86) | Number | PCT/US2012/031063 | 
| Date | 2012-03-29 | 
| (87) | Number | WO 2012/135408 | 
| Date | 2012-10-04 | 
| (30) | Number | Date | Country code | 
| 201161470121 P | 2011-03-31 | US | 
| (72) | 
                    
                    
                    
                    
                    SHARMA, Manoj K., US  
                    
                    
                    
                    
                    NARASIMHAN, Chakravarthy Nachu, US  
                    
                    
                    
                    
                    GERGICH, Kevin James, US  
                    
                    
                    
                    
                    KANG, Soonmo Peter, US  | 
| (73) | Merck Sharp & Dohme Corp.,
                126 East Lincoln Avenue, Rahway, NJ 07065-0907,
                US | 
| (74) | Jurga PETNIŪNAITĖ,
                AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
                LT | 
| (54) | Stabilios antikūnų kompozicijos prieš žmogaus programuojamos mirties receptorių PD-1 ir susiję gydymo būdai | 
| STABLE FORMULATIONS OF ANTIBODIES TO HUMAN PROGRAMMED DEATH RECEPTOR PD-1 AND RELATED TREATMENTS | 
| Payment date | Validity (years) | Amount | |
| 2025-02-10 | 14 | 289.00 EUR | 
| 2026-03-29 |